Innoblative Announces Successful First-in-Human Use of its Novel Electrosurgical Device for Breast Cancer Treatment Read More » July 29, 2024
Additional Data Published in “Annals of Surgical Oncology” Recommends Extended Monitoring of Lymphedema for Breast Cancer Patients Read More » July 29, 2024
Biotheryx Announces First Patient Dosed in Phase 1 Clinical Trial of BTX-9341, a First-in-Class, Dual Bifunctional Degrader of CDK4/6, as a Monotherapy and in Combination with Fulvestrant for HR+/HER2- Breast Cancer Read More » July 29, 2024
Tufts Medical Center Becomes First Hospital in Massachusetts to Adopt MOLLI Surgical’s Breast Cancer Technology Read More » July 29, 2024
